Gelstat Corp Stock Fundamentals

GSAC Stock  USD 0.0004  0.0001  33.33%   
GelStat Corp fundamentals help investors to digest information that contributes to GelStat Corp's financial success or failures. It also enables traders to predict the movement of GelStat Pink Sheet. The fundamental analysis module provides a way to measure GelStat Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GelStat Corp pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

GelStat Corp Company Operating Margin Analysis

GelStat Corp's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current GelStat Corp Operating Margin

    
  (127.79) %  
Most of GelStat Corp's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GelStat Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, GelStat Corp has an Operating Margin of -127.7943%. This is 264.29% higher than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The operating margin for all United States stocks is notably higher than that of the company.

GelStat Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining GelStat Corp's current stock value. Our valuation model uses many indicators to compare GelStat Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GelStat Corp competition to find correlations between indicators driving GelStat Corp's intrinsic value. More Info.
GelStat Corp is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value GelStat Corp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for GelStat Corp's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

GelStat Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GelStat Corp's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of GelStat Corp could also be used in its relative valuation, which is a method of valuing GelStat Corp by comparing valuation metrics of similar companies.
GelStat Corp is currently under evaluation in operating margin category among its peers.

GelStat Fundamentals

About GelStat Corp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze GelStat Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GelStat Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GelStat Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. Gelstat Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in GelStat Pink Sheet

GelStat Corp financial ratios help investors to determine whether GelStat Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GelStat with respect to the benefits of owning GelStat Corp security.